Anti-IL-3Ra / CD123 Reference Antibody (SNG-CD123A)
- Product Code: 140236
| Molecular Weight: | Molecular Formula: | ||
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | -20℃ |
Product Description:
Used in targeted cancer therapies, particularly for hematologic malignancies such as acute myeloid leukemia (AML) and blastic plasmacytoid dendritic cell neoplasm (BPDCN). Binds specifically to the IL-3 receptor alpha chain (CD123), which is overexpressed on leukemic stem cells and certain immune-derived cancer cells. This selective binding enables the antibody to deliver cytotoxic agents directly to tumor cells when used as part of antibody-drug conjugates (ADCs), or to flag cancer cells for destruction by the immune system through mechanisms like antibody-dependent cellular cytotoxicity (ADCC). Also investigated in chimeric antigen receptor (CAR) T-cell therapies where it serves as a targeting domain to direct engineered T cells to CD123-positive malignancies. Its high specificity makes it valuable in minimizing damage to healthy tissues while improving therapeutic efficacy.
Sizes / Availability / Pricing:
| Size | Availability | Price | Quantity |
|---|---|---|---|
| 50μg | 10-20 days | ฿4,980.00 |
+
-
|
Anti-IL-3Ra / CD123 Reference Antibody (SNG-CD123A)
Used in targeted cancer therapies, particularly for hematologic malignancies such as acute myeloid leukemia (AML) and blastic plasmacytoid dendritic cell neoplasm (BPDCN). Binds specifically to the IL-3 receptor alpha chain (CD123), which is overexpressed on leukemic stem cells and certain immune-derived cancer cells. This selective binding enables the antibody to deliver cytotoxic agents directly to tumor cells when used as part of antibody-drug conjugates (ADCs), or to flag cancer cells for destruction by the immune system through mechanisms like antibody-dependent cellular cytotoxicity (ADCC). Also investigated in chimeric antigen receptor (CAR) T-cell therapies where it serves as a targeting domain to direct engineered T cells to CD123-positive malignancies. Its high specificity makes it valuable in minimizing damage to healthy tissues while improving therapeutic efficacy.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Purchase History for
Loading purchase history...
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :